News

Los Angeles-"An assessment of ocular motility is a component of a comprehensive ophthalmologic examination. Therefore, it should be carried out even in the absence of complaints referable to the ocular motor system," said Howard R. Krauss, MD, clinical professor of ophthalmology, Jules Stein Eye Institute, and clinical professor of neurosurgery, UCLA, Los Angeles. "More detailed ocular motor tests can be performed when clinically indicated."

New York-Differentiating the classic embolic visual loss of amaurosis fugax from the numerous other causes of transient visual loss involves careful evaluation. Mark J. Kupersmith, MD, described how to differentiate among the various causes of transient visual disturbance and target the necessary diagnostic procedures.

Philadelphia-Cerebrovascular dissection represents a life-and-death situation for the patient. Ophthalmologists should be able to recognize this potentially catastrophic diagnosis and initiate emergent treatment, said Nicholas Volpe, MD.

Dallas-A sleep study should be performed in patients who have an elevated C-reactive protein (CRP) level and biopsy-negative ischemic optic neuropathy. Elevated CRP may be a marker for sleep apnea-associated optic neuropathy, according to John G. McHenry, MD.

Monterey Park, CA-Latanoprost (Xalatan, Pfizer) may be an alternative treatment for blepharospasm. Ted C. Wei Jr., MD, reported that 75% of his patients had moderate to complete resolution of symptoms after latanoprost was prescribed.

St. Louis-When the rule of the pupil was first described in 1958 by Wilbur Rucker, MD, there were specific guidelines to follow if the pupillary reaction was normal and if it was not; in the first case, paralysis is likely due to occlusive vascular disease and in the second case to aneurysm.

Rockville Center, NY-Nedocromil sodium is the mainstay of therapy for patients who need chronic medication because it offers continued relief without the development of tolerance.

Fort Lauderdale, FL-Ophthalmic epinastine HCl is a new therapy for symptomatic relief of seasonal allergic conjunctivitis that is at least as effective and well tolerated as ketotifen fumarate (Zaditor, Novartis Pharmaceuticals, Duluth, GA), reported Stefano Bonini, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.

Cleveland-A series of ongoing clinical trials helps the clinician better understand the proper timing and selection of photodynamic therapy (PDT) with verteporfin (Visudyne, QLT Phototherapeutics/Novartis Ophthalmics) for age-related macular degeneration (AMD), said Peter K. Kaiser, MD, staff physician at the Cole Eye Institute, Cleveland Clinic Foundation.

Des Plaines, IL-Second-quarter sales for Addition Technology Inc.'s Intacs micro-thin prescription inserts for surgical vision correction increased 51% over the same quarter last year and 7% over the first quarter of 2004.

Irvine, CA-Refractec Inc. is reporting record sales and procedures performed with its ViewPoint CK System, which performs conductive keratoplasty (CK) to treat presbyopia.

Fairfax, VA-The American Society of Cataract and Refractive Surgery (ASCRS) will hold its first Summer Refractive Congress at the Fairmont Olympic Hotel in Seattle next August.

New York-The muscarinic inhibitor, atropine, has been shown to slow the growth of axial length in the short term in children treated once daily, according to Mitsugu Shimmyo, MD.

San Diego-Surface ablation techniques such as PRK and LASEK can be considered in eyes with highly irregular astigmatism that have previously undergone LASIK or RK, according to Gustavo E. Tamayo, MD, who spoke during the annual meeting of the American Society of Cataract and Refractive Surgery.

New York-The ideal monitor of glaucoma progression should have high sensitivity, high specificity, be resistant to fluctuations of the condition, require few confirmatory tests, have broad sensitivity at all stages of the disease, and be easy to interpret, according to David S. Greenfield, MD, who spoke at the Glaucoma 2004 meeting here.

It’s sometimes challenging being a child who wears glasses, so a few cool accessories can turn the experience into a more enjoyable one.

Rochester, NY-Bausch & Lomb and CIBA Vision Corp. have settled longstanding patent infringement lawsuits related to silicone hydrogel contact lens materials used to make their extended-wear lenses.

The pediatric eyewear market may be a rewarding and lucrative off-shoot for ophthalmologists who have already chosen to include a dispensary in their practices. Robert S. Gold, MD, of Eye Physicians of Central Florida, Orlando, offers this advice about including pediatric and youth eyewear in a busy ophthalmologic practice.

Indianapolis-Measurement of retinal oxygen utilization could provide vital clinical information about the metabolic state of the retina, according an Indiana glaucoma researcher.

San Diego-A new ophthalmic viscoelastic device (OVD) has been developed, which should be available in late 2004, that is the first to provide high viscosity as well as dispersive properties.

This IOL has no spherical aberration and will therefore not add to any pre-existing higher-order aberrations.

Decentration of an IOL increases higher-order aberrations, especially coma.

Before I tried microphaco, I asked the same question that many cataract surgeons ask about microphaco: What's the advantage of these smaller incisions if you still need to create a larger incision to implant the IOL?

San Diego-Cyclotorsional registration is an important step to optimize wavefront-guided ablations, according to refractive expert Marguerite B. McDonald, MD, who spoke during the American Society of Cataract and Refractive Surgery annual meeting.

Dorado, Puerto Rico-LASEK has certainly gained some proponents over the last couple of years. These surgeons claim that the procedure is less painful and offers quicker visual recovery than PRK and spares tissue and avoids flap complications associated with LASIK.

Eugene, OR-Three-year FDA clinical trial results establish the efficacy of the myopic Implantable Contact Lens (ICL, STAAR Surgical) for correcting –3 to –20 D of myopia and substantiate its overall safety in patients with moderate to high myopia, said I. Howard Fine, MD.

San Diego-In eyes treated with the Zyoptix Customized Ablation System (Bausch & Lomb, Rochester, NY), outcomes analysis demonstrated improvements in contrast sensitivity and higher-order aberrations in eyes treated with large optical zones of 6.5 to 7 mm and in those that had greater higher-order aberrations before treatment.

Norfolk, VA-A new formulation of the oral nutraceutical HydroEye featuring added lutein (HydroEye Plus Lutein, ScienceBased Health) acknowledges the potential benefits of dietary manipulation on ocular disease, emphasizes prevention, and improves cost-effectiveness and compliance for patients, said John D. Sheppard, MD.